Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: December 2020

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Featured in Syndicated Broadcast

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it was featured in a broadcast via NetworkNewsAudio (“NNA”), a solution … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures $12M in Registered Direct Offering

Genprex (NASDAQ: GNPX), focused on developing life-changing therapies for patients with cancer and diabetes, has announced the closing of its registered direct offering of 3,116,884 shares of its common stock with a single health care-dedicated institutional investor. Genprex secured gross … Continue reading

Posted in Genprex Inc. GNPX, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Featured in Equity Research Report

VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was featured in an equity research report by Maxim Group LLC. The piece discusses VistaGen’s strongest positioning yet, based on … Continue reading

Posted in MissionIRNewsBreaks, VistaGen Therapeutics Inc. VTGN | Leave a comment

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Integrates Data, AI to Pave Path for Better Health Outcomes

Predictive Oncology (NASDAQ: POAI), a knowledge-driven precision medicine company focused on applying data and artificial intelligence (“AI”) to personalized medicine and drug discovery, is positioned to play a critical role in the precision oncology industry. The company integrates AI technology … Continue reading

Posted in Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Sustainable Green Team Ltd. (SGTM) Initiates Strategic Engagement to Transpire Vision, Achieve NASDAQ Uplisting

Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, recently engaged Anthony L.G. PLLC to initiate the FORM-10 process to become fully reporting, assist with all SEC legal matters and uplist … Continue reading

Posted in Sustainable Green Team Ltd. SGTM | Leave a comment

Sustainable Green Team Ltd. (SGTM) Offers Relatively Stable Investment Opportunity in Ethical – and Profitable – Company

Recent interview on CNBC featured prominent analyst advising investors against “egregiously expensive” tech stocks SGTM is profitable company that transforms natural waste into organic gardening products, playground surface material Recent financial results include Q3 revenue of $5.9 million, 4,817% increase … Continue reading

Posted in Sustainable Green Team Ltd. SGTM | Leave a comment

MissionIRNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Confirms Resolution in Annual General Meeting

iClick Interactive Asia Group Limited (NASDAQ: ICLK), a China-based company, has shared the results of its annual shareholder general meeting; the meeting was held Dec. 23, 2020, in Hong Kong. During the meeting, iClick shareholders approved and ratified the appointment of … Continue reading

Posted in iClick Interactive Asia Group Ltd. ICLK, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Creatd Inc. (NASDAQ: CRTD) Provides Update on Proprietary Platform Performance in 2020

Creatd (NASDAQ: CRTD), the parent company of Vocal, has released a year-in-review overview for the proprietary technology platform. The update spotlights the creators, stories and milestones that distinguished the platform throughout 2020. In addition, the update notes how Vocal supported … Continue reading

Posted in Creatd Inc. CRTD, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Closes $100M Underwritten Public Offering

VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, has announced the closing of its $100 million underwritten public offering. The offering consisted of 63,000,000 shares of its common … Continue reading

Posted in VistaGen Therapeutics Inc. VTGN | Leave a comment

MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Enters into Estimated $12-Million Securities Purchase Agreement

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has entered into a securities purchase agreement with a single healthcare-dedicated institutional investor. The agreement outlines the purchase and sale of … Continue reading

Posted in Genprex Inc. GNPX, MissionIRNewsBreaks | Leave a comment